Virus News and Research

Latest Virus News and Research

Researchers secure $12 million grant to develop improved therapies for hemophilia

An Indiana University School of Medicine researcher will lead a multi-institute effort toward improved therapies for hemophilia with help from a $12 million grant from the National Heart Lung and Blood Institute.

8 Mar 2022

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Sexual partnerships between individuals from different communities may help explain why some community-based HIV prevention efforts were moderately effective, shows a study published in eLife.

8 Mar 2022

Three new drug companies join the COVIDRIVE consortium to study vaccine effectiveness

Three new drug companies (Moderna, Novavax and Valneva) have joined the COVIDRIVE consortium, becoming partners of this project coordinated by the Vaccine Research Department of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (Fisabio), an affiliate of the Conselleria de Sanitat Universal i Salut Pública, along with the company specialized in pharmacovigilance and epidemiology, P95.

8 Mar 2022

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

Researchers describe a method to safely sanitize an occupied room using ultraviolet (UV)-C radiation.

8 Mar 2022

A new view of SARS-CoV-2 genome structure

Researchers performed DMS mutational profiling with sequencing and DREEM clustering to determine the SARS-CoV-2 RNA secondary structure.

8 Mar 2022

Durable selenium nanoparticle fabrics with antiviral and antibacterial properties

Researchers graft SeNPs on polyester fabric through a flat screen-printing technique and observed their antimicrobial activity.

8 Mar 2022

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Prime Minister Boris Johnson today announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42million to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 - the virus that causes COVID-19 - as well as other major coronaviruses, including those that cause SARS and MERS.

8 Mar 2022

Third-party physicians prescribe more antibiotics through telehealth than hospital-affiliated doctors

During the COVID-19 pandemic, the demand for telemedicine boomed – increasing 63-fold among Medicare users alone from approximately 840,000 telehealth visits in 2019 to 52.7 million in 2020.

8 Mar 2022

Research shows how COVID-19 lockdowns took support away from people with mental health issues

The COVID-19 pandemic significantly affected people with long-term mental health issues by damaging or taking away their support structures, new research from the University of Huddersfield has found.

8 Mar 2022

Researchers come one step closer to reversing the destructive aging process in egg cells

Throughout much of the world, increasing numbers of women are delaying having their first child until they are in their late thirties, and even into their forties.

8 Mar 2022

A promising approach for COVID-19 prophylaxis

SARS-CoV-2 viruses can hide from recognition by the immune system. However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections.

8 Mar 2022

Intersectional, anterograde transsynaptic targeting system used to reveal two different brain circuits

Osaka Metropolitan University uses new “intersectional, anterograde transsynaptic targeting system” to reveal two different mouse brain circuits: the retina/primary visual cortex to the superior colliculus and the bilateral motor cortex to the dorsal striatum.

8 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

Researchers developed a highly thermo-tolerant vaccine candidate that elicited high nAb titers in mice against several SARS-CoV-2 variants of concerns.

8 Mar 2022

VOYAGER adjustable tip spacing pipette increases productivity in a real-life situation

INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipettes save time and improve lab productivity, and the company has created a testimonial video showcasing the pipette’s many useful features.

From INTEGRA Biosciences 8 Mar 2022

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Researchers presented a technique called rapid in vitro inhibition assay (RIVIA), whereby potential SARS-CoV-2 antibody and nanobody candidates can be rapidly screened.

8 Mar 2022

Current and future perspectives of mRNA technology

New research reports on the current and future perspectives on messenger ribonucleic acid technology, the platform on which the first successful COVID-19 vaccine was based.

8 Mar 2022

Effect of COVID-19 mRNA vaccine on in vitro glial cells of the brain studied by Raman spectroscopy and imaging

Researchers studied how the mRNA-based BNT162b2 COVID-19 vaccine altered the biochemical composition of glial and glioma brain cells in vitro.

8 Mar 2022

Comparative immunogenicity of reduced and standard BNT162b2 and mRNA-1273 boosters in CoronaVac vaccinees

Researchers compared the immunogenicity of the reduced and standard doses of the BNT162b2 and mRNA-1273 vaccine in adults immunized with two doses of the CoronaVac vaccine.

8 Mar 2022

The NFL has been using an unproven measure to get players with covid back on the field fast

Two months before the Super Bowl, the omicron surge was decimating NFL rosters as players tested positive for covid-19. In mid-December, the NFL postponed a game between the Los Angeles Rams and the Seattle Seahawks because the Rams, who would go on to win the Super Bowl, had 29 players out with covid.

8 Mar 2022

Virus News and Research

Latest Virus News and Research

Researchers secure $12 million grant to develop improved therapies for hemophilia

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Three new drug companies join the COVIDRIVE consortium to study vaccine effectiveness

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

A new view of SARS-CoV-2 genome structure

Durable selenium nanoparticle fabrics with antiviral and antibacterial properties

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Third-party physicians prescribe more antibiotics through telehealth than hospital-affiliated doctors

Research shows how COVID-19 lockdowns took support away from people with mental health issues

Researchers come one step closer to reversing the destructive aging process in egg cells

A promising approach for COVID-19 prophylaxis

Intersectional, anterograde transsynaptic targeting system used to reveal two different brain circuits

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

VOYAGER adjustable tip spacing pipette increases productivity in a real-life situation

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Current and future perspectives of mRNA technology

Effect of COVID-19 mRNA vaccine on in vitro glial cells of the brain studied by Raman spectroscopy and imaging

Comparative immunogenicity of reduced and standard BNT162b2 and mRNA-1273 boosters in CoronaVac vaccinees

The NFL has been using an unproven measure to get players with covid back on the field fast

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in